tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market
ASND
Ascendis Pharma
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Ascendis Pharma (ASND) Stock News & Sentiment

Compare
599 Followers
Ascendis Pharma’s Yorvipath Shows Long-Term Kidney Benefits, Boosting Buy Rating
Premium
Ratings
Ascendis Pharma’s Yorvipath Shows Long-Term Kidney Benefits, Boosting Buy Rating
4d ago
ASND
Ascendis Pharma’s Yorvipath: Strong Phase 3 Results and Market Adoption Drive Buy Rating
Premium
Ratings
Ascendis Pharma’s Yorvipath: Strong Phase 3 Results and Market Adoption Drive Buy Rating
4d ago
ASND
Ascendis Pharma’s Cancer Study Termination: Implications for Investors
Premium
Company Announcements
Ascendis Pharma’s Cancer Study Termination: Implications for Investors
7d ago
ASND
Ascendis Pharma Grants Warrants to Employees to Boost Engagement
Premium
Company Announcements
Ascendis Pharma Grants Warrants to Employees to Boost Engagement
9d ago
6K
ASND
Positive Outlook for Ascendis Pharma Driven by Yorvipath’s Growing Adoption and Revenue Potential
Premium
Ratings
Positive Outlook for Ascendis Pharma Driven by Yorvipath’s Growing Adoption and Revenue Potential
10d ago
ASND
Ascendis Pharma Closes Warrant Exercise Window, Boosts Share Capital
Premium
Company Announcements
Ascendis Pharma Closes Warrant Exercise Window, Boosts Share Capital
21d ago
6K
ASND
Ascendis Pharma’s Competitive Edge in Achondroplasia Treatment: Buy Rating Supported by TransCon CNP’s Potential and Yorvipath Launch
Premium
Ratings
Ascendis Pharma’s Competitive Edge in Achondroplasia Treatment: Buy Rating Supported by TransCon CNP’s Potential and Yorvipath Launch
22d ago
ASND
More ASND News >

ASND News on the Web

Wall Street Analysts Believe Ascendis Pharma (ASND) Could Rally 29.83%: Here's is How to Trade
Zacks
Bullish
Why Ascendis Pharma A/S’s (ASND) Stock Is Up 5.41%
AAII
Neutral
Analysts Conflicted on These Healthcare Names: Milestone Pharmaceuticals (MIST), Exact Sciences (EXAS) and Ascendis Pharma (ASND)
TipRanks News
Neutral
Biotech Stocks Facing FDA Decision In July 2025
rttnews
Neutral
UBS Keeps Their Buy Rating on Ascendis Pharma (ASND)
TipRanks News
Neutral
Why Ascendis Pharma A/S’s (ASND) Stock Is Down 5.17%
AAII
Neutral
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Abbott Laboratories (ABT) and I-MAB (IMAB)
TipRanks News
Neutral
Bank of America Securities Remains a Buy on Ascendis Pharma (ASND)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
ASND
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ASND’s Media Buzz Sentiment?
1 articles about ASND were published this week. In an average week, 1.75 articles are published.
    What is ASND’s weekly average amount of articles?
    In an average week, 1.75 articles about ASND are published.
      What is ASND’s News Sentiment?
      100% of articles about ASND were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        NEVIPascal Biosciences Inc
        JNJJohnson & Johnson
        HRMYHarmony Biosciences Holdings
        ABTAbbott Laboratories
        WATWaters
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing